Toho Holdings Co., Ltd. (8129.T)
JPY 4661.0
(-0.53%)
JPY 4661.0
(-0.53%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 25.84 Billion JPY | 0.14% |
| 2022 | 19.22 Billion JPY | 1.51% |
| 2021 | 19.48 Billion JPY | 45.26% |
| 2020 | 10.86 Billion JPY | -41.2% |
| 2019 | 30.11 Billion JPY | 6.06% |
| 2018 | 27.38 Billion JPY | -11.48% |
| 2017 | 29.7 Billion JPY | 18.61% |
| 2016 | 28.63 Billion JPY | -36.66% |
| 2015 | 42.6 Billion JPY | 82.71% |
| 2014 | 29.08 Billion JPY | -4.61% |
| 2013 | 24.41 Billion JPY | -1.21% |
| 2012 | 25.31 Billion JPY | -34.9% |
| 2011 | 24.69 Billion JPY | 31.14% |
| 2010 | 12.99 Billion JPY | -9.29% |
| 2009 | 18.66 Billion JPY | 99.01% |
| 2008 | 1.73 Billion JPY | -42.44% |
| 2007 | 15.63 Billion JPY | 5.18% |
| 2006 | 13.55 Billion JPY | 137.73% |
| 2005 | 8.29 Billion JPY | 40.37% |
| 2004 | 6.88 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 3.9 Billion JPY | -53.64% |
| 2023 Q2 | 6.97 Billion JPY | 71.44% |
| 2023 FY | - JPY | 0.14% |
| 2023 Q1 | 4.06 Billion JPY | -45.42% |
| 2023 Q4 | 9.39 Billion JPY | 39.83% |
| 2023 Q3 | 6.72 Billion JPY | -3.66% |
| 2022 Q3 | 7.52 Billion JPY | 31.4% |
| 2022 Q2 | 5.73 Billion JPY | 24.7% |
| 2022 Q1 | 4.59 Billion JPY | -54.0% |
| 2022 FY | - JPY | 1.51% |
| 2022 Q4 | 7.45 Billion JPY | -0.98% |
| 2021 Q2 | 4.17 Billion JPY | 6.26% |
| 2021 FY | - JPY | 45.26% |
| 2021 Q1 | 3.92 Billion JPY | -17.75% |
| 2021 Q3 | 6.64 Billion JPY | 59.04% |
| 2021 Q4 | 9.98 Billion JPY | 50.44% |
| 2020 Q1 | 4.84 Billion JPY | -30.94% |
| 2020 Q2 | 2.19 Billion JPY | -54.7% |
| 2020 Q3 | 5.12 Billion JPY | 133.49% |
| 2020 Q4 | 4.77 Billion JPY | -6.79% |
| 2020 FY | - JPY | -41.2% |
| 2019 Q2 | 7.45 Billion JPY | 13.77% |
| 2019 Q4 | 7.01 Billion JPY | -18.2% |
| 2019 FY | - JPY | 6.06% |
| 2019 Q1 | 6.54 Billion JPY | -24.89% |
| 2019 Q3 | 8.57 Billion JPY | 15.13% |
| 2018 Q3 | 8.61 Billion JPY | 56.69% |
| 2018 Q4 | 8.71 Billion JPY | 1.23% |
| 2018 FY | - JPY | -11.48% |
| 2018 Q1 | 5.07 Billion JPY | -53.79% |
| 2018 Q2 | 5.49 Billion JPY | 8.29% |
| 2017 Q4 | 10.98 Billion JPY | 23.29% |
| 2017 Q3 | 8.91 Billion JPY | 44.22% |
| 2017 Q2 | 6.17 Billion JPY | 13.32% |
| 2017 Q1 | 5.45 Billion JPY | -6.32% |
| 2017 FY | - JPY | 18.61% |
| 2016 Q2 | 6.95 Billion JPY | -0.11% |
| 2016 Q3 | 6.83 Billion JPY | -1.74% |
| 2016 FY | - JPY | -36.66% |
| 2016 Q4 | 5.82 Billion JPY | -14.86% |
| 2016 Q1 | 6.96 Billion JPY | -60.46% |
| 2015 FY | - JPY | 82.71% |
| 2015 Q3 | 11.5 Billion JPY | 71.75% |
| 2015 Q4 | 17.61 Billion JPY | 53.05% |
| 2015 Q2 | 6.7 Billion JPY | 9.23% |
| 2015 Q1 | 6.13 Billion JPY | 12.53% |
| 2014 Q3 | 8.48 Billion JPY | 222.38% |
| 2014 Q4 | 5.45 Billion JPY | -35.75% |
| 2014 FY | - JPY | -4.61% |
| 2014 Q1 | 6.39 Billion JPY | 28.95% |
| 2014 Q2 | 2.63 Billion JPY | -58.85% |
| 2013 Q2 | 5.49 Billion JPY | 1.66% |
| 2013 Q4 | 4.96 Billion JPY | -39.62% |
| 2013 FY | - JPY | -1.21% |
| 2013 Q1 | 5.4 Billion JPY | -30.41% |
| 2013 Q3 | 8.21 Billion JPY | 49.45% |
| 2012 Q3 | -2.1 Billion JPY | -121.27% |
| 2012 FY | - JPY | -34.9% |
| 2012 Q1 | 8.81 Billion JPY | -28.14% |
| 2012 Q2 | 9.89 Billion JPY | 12.3% |
| 2012 Q4 | 7.76 Billion JPY | 469.03% |
| 2011 Q4 | 12.26 Billion JPY | 28.38% |
| 2011 FY | - JPY | 31.14% |
| 2011 Q1 | 7.64 Billion JPY | 57.1% |
| 2011 Q2 | 7.97 Billion JPY | 4.38% |
| 2011 Q3 | 9.55 Billion JPY | 19.73% |
| 2010 Q1 | 8.61 Billion JPY | -11.69% |
| 2010 Q4 | 4.86 Billion JPY | -30.49% |
| 2010 FY | - JPY | -9.29% |
| 2010 Q3 | 6.99 Billion JPY | -13.29% |
| 2010 Q2 | 8.07 Billion JPY | -6.31% |
| 2009 Q4 | 9.75 Billion JPY | 8.58% |
| 2009 Q1 | 6.22 Billion JPY | 228.62% |
| 2009 Q2 | 6.5 Billion JPY | 4.48% |
| 2009 FY | - JPY | 99.01% |
| 2009 Q3 | 8.98 Billion JPY | 38.18% |
| 2008 Q2 | 1.04 Billion JPY | 0.0% |
| 2008 Q3 | 6.04 Billion JPY | 476.17% |
| 2008 Q4 | 1.89 Billion JPY | -68.66% |
| 2008 FY | - JPY | -42.44% |
| 2007 FY | - JPY | 5.18% |
| 2006 FY | - JPY | 137.73% |
| 2005 FY | - JPY | 40.37% |
| 2004 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 6.02 Billion JPY | -329.248% |
| Takeda Pharmaceutical Company Limited | 874.6 Billion JPY | 97.045% |
| Sumitomo Pharma Co., Ltd. | -281.07 Billion JPY | 109.195% |
| Shionogi & Co., Ltd. | 186.7 Billion JPY | 86.157% |
| Wakamoto Pharmaceutical Co.,Ltd. | 570.97 Million JPY | -4426.492% |
| Nippon Shinyaku Co., Ltd. | 36.29 Billion JPY | 28.782% |
| Kaken Pharmaceutical Co., Ltd. | 12.26 Billion JPY | -110.687% |
| Eisai Co., Ltd. | 103.1 Billion JPY | 74.934% |
| Morishita Jintan Co., Ltd. | 1.29 Billion JPY | -1898.84% |
| Hisamitsu Pharmaceutical Co., Inc. | 18.34 Billion JPY | -40.921% |
| Mochida Pharmaceutical Co., Ltd. | 8.97 Billion JPY | -188.031% |
| Fuso Pharmaceutical Industries,Ltd. | 3.67 Billion JPY | -604.223% |
| Nippon Chemiphar Co., Ltd. | 1.4 Billion JPY | -1742.124% |
| Tsumura & Co. | 30.77 Billion JPY | 16.011% |
| Kissei Pharmaceutical Co., Ltd. | 18.72 Billion JPY | -38.061% |
| Torii Pharmaceutical Co., Ltd. | 5.27 Billion JPY | -390.324% |
| Towa Pharmaceutical Co., Ltd. | 35.53 Billion JPY | 27.271% |
| Fuji Pharma Co., Ltd. | 6.88 Billion JPY | -275.545% |
| Zeria Pharmaceutical Co., Ltd. | 17.52 Billion JPY | -47.503% |
| KYORIN Holdings, Inc. | 10.29 Billion JPY | -151.02% |
| Taiko Pharmaceutical Co.,Ltd. | -3.75 Billion JPY | 789.2% |
| Daito Pharmaceutical Co.,Ltd. | 7.55 Billion JPY | -242.182% |
| SymBio Pharmaceuticals Limited | -714 Million JPY | 3719.748% |
| MedRx Co., Ltd | -884.51 Million JPY | 3021.937% |
| Mizuho Medy Co.,Ltd. | 5.53 Billion JPY | -366.829% |
| Solasia Pharma K.K. | -635 Million JPY | 4170.079% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 1188.704% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 9.16 Billion JPY | -182.058% |
| Sawai Group Holdings Co., Ltd. | 36.87 Billion JPY | 29.908% |
| Cyfuse Biomedical K.K. | -538.28 Million JPY | 4901.324% |
| Koa Shoji Holdings Co.,Ltd. | 5.1 Billion JPY | -406.602% |